ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.
Clinical trial NCT00077636 · COMPLETED
Trial details
- NCT number
- NCT00077636
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Primary completion
- 2006-03-01
- Enrollment
- 1469
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.